The Effect of Inhalation of Lavender Extract on Pain Caused by Airway Suctioning in Mechanically Ventilated Patients

Investigating the effect of lavender extract inhalation on pain caused by airway suction in patients undergoing mechanical ventilation with a tracheal tube and tracheostomy hospitalized in the special care department; A double-blind randomized clinical trial

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20141026019677N7

Enrollment

Registered

2025-04-23

Start date

2025-04-21

Completion date

Unknown

Last updated

2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain. Pain, not elsewhere classified

Interventions

Intervention 1: Intervention Group: In this group, under the supervision of the research assistant, 2% extract of Lavandula angustifolia (prepared by Barij Company) will be used prior to suctioning. P

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: The patient should be admitted to the ICU for at least 24 hours. The patient must have a history of suctioning during the current or previous hospitalization. The patient should not be in pain from long-term illnesses like cancer or after surgery. The person should not have used painkillers or sedatives for at least six hours before and during the intervention. Patient must be on mechanical ventilation with an endotracheal tube or tracheostomy.

Exclusion criteria

Exclusion criteria: The patient is either under 18 or over 60. The patient is pregnant. has a History of opioid abuse. The patient has a history of neuropsychiatric illness.

Design outcomes

Primary

Measure	Time frame
Pain. Timepoint: Right before the start of the suction procedure (intervention); 5 minutes after the start of the intervention. Method of measurement: Use of the CPOT Tool (Critical-Care Pain Observation Tool).	—

Secondary

Measure	Time frame
Blood Oxygen saturation (SpO2). Timepoint: Before the intervention, 5 minutes after the start of the intervention, 5 minutes after the end of the intervention, and 10 minutes after the end of the intervention. Method of measurement: With use of Monitoring devices.;Blood pressure. Timepoint: Before the intervention, 5 minutes after the start of the intervention, 5 minutes after the end of the intervention, and 10 minutes after the end of the intervention. Method of measurement: With use of Monitoring devices.;Heart rate. Timepoint: Before the intervention, 5 minutes after the start of the intervention, 5 minutes after the end of the intervention, and 10 minutes after the end of the intervention. Method of measurement: With use of Monitoring devices.	—

Measure

Time frame

Blood Oxygen saturation (SpO2). Timepoint: Before the intervention, 5 minutes after the start of the intervention, 5 minutes after the end of the intervention, and 10 minutes after the end of the intervention. Method of measurement: With use of Monitoring devices.;Blood pressure. Timepoint: Before the intervention, 5 minutes after the start of the intervention, 5 minutes after the end of the intervention, and 10 minutes after the end of the intervention. Method of measurement: With use of Monitoring devices.;Heart rate. Timepoint: Before the intervention, 5 minutes after the start of the intervention, 5 minutes after the end of the intervention, and 10 minutes after the end of the intervention. Method of measurement: With use of Monitoring devices.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactRavanbakhsh Esmaeili

Mazandaran University of Medical Sciences

r.esmaeili@mazums.ac.ir+98 11 3336 7345

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026